Fluorescent macromolecular sensors of enzymatic activity for in vivo imaging

Progress in Molecular Biology and Translational Science

Volumn 113, Issue , 2013, Pages 349-387

  Bogdanov, Alexei A ^a   Mazzanti, Mary L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cyanine; Enzyme; Fluorescence; Graft copolymer; Near infrared

Indexed keywords

EID: 84871051464     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386932-6.00009-0     Document Type: Chapter

References (132)

1. A.M. Cataldo, and R.A. Nixon Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain Proc Natl Acad Sci USA 87 1990 3861 3865
2. D.R. Edwards, and G. Murphy Cancer. Proteases - invasion and more Nature 394 1998 527 528
3. J. Fang, Y. Shing, D. Wiederschain, L. Yan, C. Butterfield, and G. Jackson Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model Proc Natl Acad Sci USA 97 2000 3884 3889 (Pubitemid 30226056)
4. G.I. Murray, M.E. Duncan, P. O'Neil, W.T. Melvin, and J.E. Fothergill Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer Nat Med 2 1996 461 462 (Pubitemid 26191919)
5. A.F. Chambers, and L.M. Matrisian Changing views of the role of matrix metalloproteinases in metastasis J Natl Cancer Inst 89 1997 1260 1270 (Pubitemid 27371946)
6. J. Folkman Angiogenic zip code Nat Biotechnol 17 1999 749 (Pubitemid 29365096)
7. B. Davidson, I. Goldberg, J. Kopolovic, L. Lerner-Geva, W.H. Gotlieb, and G. Ben-Baruch MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization Gynecol Oncol 73 1999 372 382 (Pubitemid 29272858)
8. H. Kanayama, K. Yokota, Y. Kurokawa, Y. Murakami, M. Nishitani, and S. Kagawa Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer Cancer 82 1998 1359 1366 (Pubitemid 28155399)
9. M. Sakakibara, S. Koizumi, Y. Saikawa, H. Wada, T. Ichihara, and H. Sato Membrane-type matrix metalloproteinase-1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastoma Cancer 85 1999 231 239 (Pubitemid 29031379)
10. D.R. Shalinsky, J. Brekken, H. Zou, C.D. McDermott, P. Forsyth, and D. Edwards Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials Ann N Y Acad Sci 878 1999 236 270 (Pubitemid 29353575)
11. H.W. Smith, and C.J. Marshall Regulation of cell signalling by uPAR Nat Rev Mol Cell Biol 11 2010 23 36
12. C. Jedeszko, and B.F. Sloane Cysteine cathepsins in human cancer Biol Chem 385 2004 1017 1027 (Pubitemid 39600309)
13. M.M. Mohamed, and B.F. Sloane Cysteine cathepsins: multifunctional enzymes in cancer Nat Rev Cancer 6 2006 764 775 (Pubitemid 44450465)
14. D. Keppler, M. Sameni, K. Moin, T. Mikkelsen, C.A. Diglio, and B.F. Sloane Tumor progression and angiogenesis: cathepsin B & Co Biochem Cell Biol 74 1996 799 810 (Pubitemid 126733741)
15. J.A. Foekens, J. Kos, H.A. Peters, M. Krasovec, M.P. Look, and N. Cimerman Prognostic significance of cathepsins B and L in primary human breast cancer J Clin Oncol 16 1998 1013 1021 (Pubitemid 28108735)
16. N. Harbeck, U. Alt, U. Berger, A. Kruger, C. Thomssen, and F. Janicke Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy Clin Cancer Res 7 2001 2757 2764 (Pubitemid 32911381)
17. M. Jagodic, I. Vrhovec, S. Borstnar, and T. Cufer Prognostic and predictive value of cathepsins D and L in operable breast cancer patients Neoplasma 52 2005 1 9 (Pubitemid 40327519)
18. M. Garcia, N. Platet, E. Liaudet, V. Laurent, D. Derocq, and J.P. Brouillet Biological and clinical significance of cathepsin D in breast cancer metastasis Stem Cells 14 1996 642 650 (Pubitemid 26404616)
19. C. Schneider, and A. Pozzi Cyclooxygenases and lipoxygenases in cancer Cancer Metastasis Rev 30 2011 277 294
20. V. Cortez, B.C. Nair, D. Chakravarty, and R.K. Vadlamudi Integrin-linked kinase 1: role in hormonal cancer progression Front Biosci (Schol Ed) 3 2011 788 796
21. J.W. Erickson, and R.A. Cerione Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget 1 2010 734 740
22. C.H. Macphee, J.J. Nelson, and A. Zalewski Lipoprotein-associated phospholipase A2 as a target of therapy Curr Opin Lipidol 16 2005 442 446
23. X. Fu, S.Y. Kassim, W.C. Parks, and J.W. Heinecke Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase J Biol Chem 276 2001 41279 41287
24. H. White Editorial: why inhibition of lipoprotein-associated phospholipase A2 has the potential to improve patient outcomes Curr Opin Cardiol 25 2010 299 301
25. M.A. Ondetti, B. Rubin, and D.W. Cushman Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents Science 196 1977 441 444 (Pubitemid 8073845)
26. S.R. Alam, D.E. Newby, and P.A. Henriksen Role of the endogenous elastase inhibitor, elafin, in cardiovascular injury: from epithelium to endothelium Biochem Pharmacol 83 2012 695 704
27. A.C. Collier, R.W. Coombs, D.A. Schoenfeld, R.L. Bassett, J. Timpone, and A. Baruch Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group N Engl J Med 334 1996 1011 1017 (Pubitemid 26124452)
28. R.Z. Orlowski Bortezomib and its role in the management of patients with multiple myeloma Expert Rev Anticancer Ther 4 2004 171 179 (Pubitemid 38477331)
29. N.G. McElvaney, H. Nakamura, P. Birrer, C.A. Hebert, W.L. Wong, and M. Alphonso Modulation of airway inflammation in cystic fibrosis. in vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor J Clin Invest 90 1992 1296 1301
30. J.M. Evans, L.A. Donnelly, A.M. Emslie-Smith, D.R. Alessi, and A.D. Morris Metformin and reduced risk of cancer in diabetic patients BMJ 330 2005 1304 1305 (Pubitemid 40813563)
31. L. Devy, S.A. Rabbani, M. Stochl, M. Ruskowski, I. Mackie, and L. Naa PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor Neoplasia 9 2007 927 937 (Pubitemid 350086438)
32. L. Devy, L. Huang, L. Naa, N. Yanamandra, H. Pieters, and N. Frans Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis Cancer Res 69 2009 1517 1526
33. R.E. Burden, J.A. Gormley, T.J. Jaquin, D.M. Small, D.J. Quinn, and S.M. Hegarty Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis Clin Cancer Res 15 2009 6042 6051
34. B.T. Elie, V. Gocheva, T. Shree, S.A. Dalrymple, L.J. Holsinger, and J.A. Joyce Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model Biochimie 92 2010 1618 1624
35. F. Leblond, S.C. Davis, P.A. Valdes, and B.W. Pogue Pre-clinical whole-body fluorescence imaging: review of instruments, methods and applications J Photochem Photobiol B 98 2010 77 94
36. E.M. Sevick-Muraca Translation of near-infrared fluorescence imaging technologies: emerging clinical applications Annu Rev Med 63 2012 217 231
37. M.V. Marshall, J.C. Rasmussen, I.-C. Tan, M.B. Aldrich, K.E. Adams, and X. Wang Near-infrared fluorescence imaging in humans with indocyanine green: a review and update Open Surg Oncol J 2 2010 12 25
38. W. Stummer, U. Pichlmeier, T. Meinel, O.D. Wiestler, F. Zanella, and H.J. Reulen Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol 7 2006 392 401
39. G.C. Feigl, R. Ritz, M. Moraes, J. Klein, K. Ramina, and A. Gharabaghi Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring J Neurosurg 113 2010 352 357
40. S.L. Troyan, V. Kianzad, S.L. Gibbs-Strauss, S. Gioux, A. Matsui, and R. Oketokoun The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping Ann Surg Oncol 16 2009 2943 2952
41. B.T. Lee, M. Hutteman, S. Gioux, A. Stockdale, S.J. Lin, and L.H. Ngo The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in perforator flap breast reconstruction Plast Reconstr Surg 126 2010 1472 1481
42. V. Ntziachristos Fluorescence molecular imaging Annu Rev Biomed Eng 8 2006 1 33 (Pubitemid 44314811)
43. E. Dimitrow, I. Riemann, A. Ehlers, M.J. Koehler, J. Norgauer, and P. Elsner Spectral fluorescence lifetime detection and selective melanin imaging by multiphoton laser tomography for melanoma diagnosis Exp Dermatol 18 2009 509 515
44. A. Poellinger, S. Burock, D. Grosenick, A. Hagen, L. Ludemann, and F. Diekmann Breast cancer: early- and late-fluorescence near-infrared imaging with indocyanine green - a preliminary study Radiology 258 2011 409 416
45. C. Goergen, H. Chen, A.J. Bogdanov, D. Sosnovik, and A. Kumar In vivo fluorescence lifetime detection of an activatable probe in infarcted myocardium J Biomed Opt 17 2012 10.1117/1.JBO.17.5.056001
46. M. Funovics, R. Weissleder, and C.H. Tung Protease sensors for bioimaging Anal Bioanal Chem 377 2003 956 963 (Pubitemid 40877826)
47. B.W. Pogue, S.C. Davis, X. Song, B.A. Brooksby, H. Dehghani, and K.D. Paulsen Image analysis methods for diffuse optical tomography J Biomed Opt 11 2006 33001
48. A.T. Kumar, E. Chung, S.B. Raymond, J.A. van de Water, K. Shah, and D. Fukumura Feasibility of in vivo imaging of fluorescent proteins using lifetime contrast Opt Lett 34 2009 2066 2068
49. A.T. Kumar, S.B. Raymond, G. Boverman, D.A. Boas, and B.J. Bacskai Time resolved fluorescence tomography of turbid media based on lifetime contrast Opt Express 14 2006 12255 12270 (Pubitemid 44907567)
50. S.H. Han, S. Farshchi-Heydari, and D.J. Hall Analytical method for the fast time-domain reconstruction of fluorescent inclusions in vitro and in vivo Biophys J 98 2010 350 357
51. D.J. Hall, U. Sunar, S. Farshchi-Heydari, and S.H. Han In vivo simultaneous monitoring of two fluorophores with lifetime contrast using a full-field time domain system Appl Opt 48 2009 D74 D78
52. J.R. Mansfield, K.W. Gossage, C.C. Hoyt, and R.M. Levenson Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging J Biomed Opt 10 2005 41207
53. S.C. Davis, H. Dehghani, J. Wang, S. Jiang, B.W. Pogue, and K.D. Paulsen Image-guided diffuse optical fluorescence tomography implemented with Laplacian-type regularization Opt Express 15 2007 4066 4082 (Pubitemid 46557568)
54. A. Sato, B. Klaunberg, and R. Tolwani In vivo bioluminescence imaging Comp Med 54 2004 631 634 (Pubitemid 44204198)
55. P. Zrazhevskiy, M. Sena, and X. Gao Designing multifunctional quantum dots for bioimaging, detection, and drug delivery Chem Soc Rev 39 2010 4326 4354
56. V. Ntziachristos, J. Ripoll, L.V. Wang, and R. Weissleder Looking and listening to light: the evolution of whole-body photonic imaging Nat Biotechnol 23 2005 313 320 (Pubitemid 41094419)
57. G. Blum, R.M. Weimer, L.E. Edgington, W. Adams, and M. Bogyo Comparative assessment of substrates and activity based probes as tools for non-invasive optical imaging of cysteine protease activity PLoS One 4 2009 e6374
58. A. Signore, S.J. Mather, G. Piaggio, G. Malviya, and R.A. Dierckx Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods Chem Rev 110 2010 3112 3145
59. B. Turk Targeting proteases: successes, failures and future prospects Nat Rev Drug Discov 5 2006 785 799 (Pubitemid 44323703)
60. D.M. Chudakov, M.V. Matz, S. Lukyanov, and K.A. Lukyanov Fluorescent proteins and their applications in imaging living cells and tissues Physiol Rev 90 2010 1103 1163
61. K. Welser, R. Adsley, B.M. Moore, W.C. Chan, and J.W. Aylott Protease sensing with nanoparticle based platforms Analyst 136 2011 29 41
62. W. Gao, B. Xing, R.Y. Tsien, and J. Rao Novel fluorogenic substrates for imaging beta-lactamase gene expression J Am Chem Soc 125 2003 11146 11147 (Pubitemid 37108021)
63. H. Maeda, N. Ishida, H. Kawauchi, and K. Tsujimura Reaction of fluorescein-isothiocyanate with proteins and amino acids. I. Covalent and non-covalent binding of fluorescein-isothiocyanate and fluorescein to proteins J Biochem 65 1969 777 783
64. T. French, P.T. So, D.J. Weaver Jr., T. Coelho-Sampaio, E. Gratton, and E.W. Voss Jr. Two-photon fluorescence lifetime imaging microscopy of macrophage-mediated antigen processing J Microsc 185 1997 339 353 (Pubitemid 27163312)
65. K. Horino, A.L. Kindezelskii, V.M. Elner, B.A. Hughes, and H.R. Petty Tumor cell invasion of model 3-dimensional matrices: demonstration of migratory pathways, collagen disruption, and intercellular cooperation FASEB J 15 2001 932 939 (Pubitemid 32290780)
66. A.J. Bogdanov, M. Mazzanti, G. Castillo, and E. Bolotin Protected graft copolymer (PGC) in imaging and therapy: a platform for the delivery of covalently and non-covalently bound drugs Theranostics 2 2012 553 576 10.7150/thno.4070
67. R. Weissleder, C.H. Tung, U. Mahmood, and A. Bogdanov Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes Nat Biotechnol 17 1999 375 378 (Pubitemid 29166041)
68. U. Mahmood, C.H. Tung, A. Bogdanov Jr., and R. Weissleder Near-infrared optical imaging of protease activity for tumor detection Radiology 213 1999 866 870
69. C.H. Tung, U. Mahmood, S. Bredow, and R. Weissleder In vivo imaging of proteolytic enzyme activity using a novel molecular reporter Cancer Res 60 2000 4953 4958
70. C. Bremer, C.H. Tung, and R. Weissleder In vivo molecular target assessment of matrix metalloproteinase inhibition Nat Med 7 2001 743 748 (Pubitemid 32588033)
71. J. Chen, C.H. Tung, U. Mahmood, V. Ntziachristos, R. Gyurko, and M.C. Fishman In vivo imaging of proteolytic activity in atherosclerosis Circulation 105 2002 2766 2771 (Pubitemid 34615149)
72. V. Ntziachristos, C.H. Tung, C. Bremer, and R. Weissleder Fluorescence molecular tomography resolves protease activity in vivo Nat Med 8 2002 757 760 (Pubitemid 34778731)
73. F.A. Jaffer, C.H. Tung, R.E. Gerszten, and R. Weissleder In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe Arterioscler Thromb Vasc Biol 22 2002 1929 1935 (Pubitemid 35315784)
74. K. Marten, C. Bremer, K. Khazaie, M. Sameni, B. Sloane, and C.H. Tung Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice Gastroenterology 122 2002 406 414 (Pubitemid 34116992)
75. C. Bremer, C.H. Tung, A. Bogdanov Jr., and R. Weissleder Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes Radiology 222 2002 814 818 (Pubitemid 34218157)
76. P. Wunderbaldinger, K. Turetschek, and C. Bremer Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe Eur Radiol 13 2003 2206 2211 (Pubitemid 37080758)
77. K. Shah, C.H. Tung, C.H. Chang, E. Slootweg, T. O'Loughlin, and X.O. Breakefield In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas Cancer Res 64 2004 273 278 (Pubitemid 38120261)
78. A. Wunder, C.H. Tung, U. Muller-Ladner, R. Weissleder, and U. Mahmood In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response Arthritis Rheum 50 2004 2459 2465 (Pubitemid 39062705)
79. S.M. Messerli, S. Prabhakar, Y. Tang, K. Shah, M.L. Cortes, and V. Murthy A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe Neoplasia 6 2004 95 105 (Pubitemid 38544597)
80. W.F. Lai, C.H. Chang, Y. Tang, R. Bronson, and C.H. Tung Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes Osteoarthritis Cartilage 12 2004 239 244 (Pubitemid 38248073)
81. M.L. Lamfers, D. Gianni, C.H. Tung, S. Idema, F.H. Schagen, and J.E. Carette Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma Cancer Res 65 2005 9398 9405 (Pubitemid 41508008)
82. J. Chen, C.H. Tung, J.R. Allport, S. Chen, R. Weissleder, and P.L. Huang Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction Circulation 111 2005 1800 1805 (Pubitemid 40525145)
83. J. Grimm, D.G. Kirsch, S.D. Windsor, C.F. Kim, P.M. Santiago, and V. Ntziachristos Use of gene expression profiling to direct in vivo molecular imaging of lung cancer Proc Natl Acad Sci USA 102 2005 14404 14409 (Pubitemid 41429710)
84. J.K. Hsiao, B. Law, R. Weissleder, and C.H. Tung In-vivo imaging of tumor associated urokinase-type plasminogen activator activity J Biomed Opt 11 2006 34013
85. J.O. Deguchi, M. Aikawa, C.H. Tung, E. Aikawa, D.E. Kim, and V. Ntziachristos Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo Circulation 114 2006 55 62 (Pubitemid 44305275)
86. M. Nahrendorf, D.E. Sosnovik, P. Waterman, F.K. Swirski, A.N. Pande, and E. Aikawa Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct Circ Res 100 2007 1218 1225 (Pubitemid 46684135)
87. F.A. Jaffer, D.E. Kim, L. Quinti, C.H. Tung, E. Aikawa, and A.N. Pande Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor Circulation 115 2007 2292 2298 (Pubitemid 46685897)
88. H. Alencar, M.A. Funovics, J. Figueiredo, H. Sawaya, R. Weissleder, and U. Mahmood Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection - study in mice Radiology 244 2007 232 238 (Pubitemid 46981978)
89. Y. Hama, Y. Urano, Y. Koyama, M. Kamiya, M. Bernardo, and R.S. Paik A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate Cancer Res 67 2007 2791 2799 (Pubitemid 46548968)
90. Y. Hama, Y. Urano, Y. Koyama, A.J. Gunn, P.L. Choyke, and H. Kobayashi A self-quenched galactosamine-serum albumin-rhodamineX conjugate: a "smart" fluorescent molecular imaging probe synthesized with clinically applicable material for detecting peritoneal ovarian cancer metastases Clin Cancer Res 13 2007 6335 6343 (Pubitemid 350075022)
91. J. Haller, D. Hyde, N. Deliolanis, R. de Kleine, M. Niedre, and V. Ntziachristos Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging J Appl Physiol 104 2008 795 802 (Pubitemid 351468809)
92. J. von Burstin, S. Eser, B. Seidler, A. Meining, M. Bajbouj, and J. Mages Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice Int J Cancer 123 2008 2138 2147
93. R.L. Scherer, M.N. VanSaun, J.O. McIntyre, and L.M. Matrisian Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon Mol Imaging 7 2008 118 131
94. R.A. Sheth, R. Upadhyay, L. Stangenberg, R. Sheth, R. Weissleder, and U. Mahmood Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model Gynecol Oncol 112 2009 616 622
95. J. Klohs, N. Baeva, J. Steinbrink, R. Bourayou, C. Boettcher, and G. Royl In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia J Cereb Blood Flow Metab 29 2009 1284 1292
96. M. Ignat, M. Aprahamian, V. Lindner, A. Altmeyer, S. Perretta, and B. Dallemagne Feasibility and reliability of pancreatic cancer staging using fiberoptic confocal fluorescence microscopy in rats Gastroenterology 137 2009 1584-92 e1
97. M. Nahrendorf, P. Waterman, G. Thurber, K. Groves, M. Rajopadhye, and P. Panizzi Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors Arterioscler Thromb Vasc Biol 29 2009 1444 1451
98. P. Habibollahi, J.L. Figueiredo, P. Heidari, A.M. Dulak, Y. Imamura, and A.J. Bass Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI Endoscopy Theranostics 2 2012 227 234
99. C.H. Tung, S. Bredow, U. Mahmood, and R. Weissleder Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging Bioconjug Chem 10 1999 892 896 (Pubitemid 29456379)
100. B.F. Sloane, S. Yan, I. Podgorski, B.E. Linebaugh, M.L. Cher, and J. Mai Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment Semin Cancer Biol 15 2005 149 157 (Pubitemid 40126246)
101. R. Zhang, M.L. Brennan, X. Fu, R.J. Aviles, G.L. Pearce, and M.S. Penn Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2001 2136 2142 (Pubitemid 34041599)
102. O. Kedem, and A. Katchalsky Thermodynamic analysis of the permeability of biological membranes to non-electrolytes Biochim Biophys Acta 27 1958 229 246
103. M.R. Dreher, W. Liu, C.R. Michelich, M.W. Dewhirst, F. Yuan, and A. Chilkoti Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers J Natl Cancer Inst 98 2006 335 344 (Pubitemid 43338213)
104. S. Qin, J.W. Seo, H. Zhang, J. Qi, F.R. Curry, and K.W. Ferrara An imaging-driven model for liposomal stability and circulation Mol Pharm 7 2010 12 21
105. J. Kim, W. Yu, K. Kovalski, and L. Ossowski Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay Cell 94 1998 353 362 (Pubitemid 28376079)
106. L.J. McCawley, and L.M. Matrisian Matrix metalloproteinases: multifunctional contributors to tumor progression Mol Med Today 6 2000 149 156 (Pubitemid 30171365)
107. E. Gherardi, W. Birchmeier, C. Birchmeier, and G. Vande Woude Targeting MET in cancer: rationale and progress Nat Rev Cancer 12 2012 89 103
108. W.G. Stetler-Stevenson, S. Aznavoorian, and L.A. Liotta Tumor cell interactions with the extracellular matrix during invasion and metastasis Annu Rev Cell Biol 9 1993 541 573
109. A.A. Bogdanov Jr., C.P. Lin, M. Simonova, L. Matuszewski, and R. Weissleder Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment Neoplasia 4 2002 228 236 (Pubitemid 34525254)
110. W. Pham, Y. Choi, R. Weissleder, and C.H. Tung Developing a peptide-based near-infrared molecular probe for protease sensing Bioconjug Chem 15 2004 1403 1407 (Pubitemid 39552031)
111. B. Law, A. Curino, T.H. Bugge, R. Weissleder, and C.H. Tung Design, synthesis, and characterization of urokinase plasminogen-activator-sensitive near-infrared reporter Chem Biol 11 2004 99 106 (Pubitemid 38203994)
112. C.H. Tung, R.E. Gerszten, F.A. Jaffer, and R. Weissleder A novel near-infrared fluorescence sensor for detection of thrombin activation in blood Chembiochem 3 2002 207 211 (Pubitemid 36004496)
113. F.J. Penna, D.A. Freilich, C. Alvarenga, and H.T. Nguyen Improving lymph node yield in retroperitoneal lymph node dissection using fluorescent molecular imaging: a novel method of localizing lymph nodes in Guinea pig model Urology 78 232 2011 e15 e18
114. T. Jiang, E.S. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings, and R.Y. Tsien Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc Natl Acad Sci USA 101 2004 17867 17872 (Pubitemid 40051978)
115. E.S. Olson, T.A. Aguilera, T. Jiang, L.G. Ellies, Q.T. Nguyen, and E.H. Wong In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer Integr Biol (Camb) 1 2009 382 393
116. D. Kato, K.M. Boatright, A.B. Berger, T. Nazif, G. Blum, and C. Ryan Activity-based probes that target diverse cysteine protease families Nat Chem Biol 1 2005 33 38
117. G. Blum, S.R. Mullins, K. Keren, M. Fonovic, C. Jedeszko, and M.J. Rice Dynamic imaging of protease activity with fluorescently quenched activity-based probes Nat Chem Biol 1 2005 203 209
118. G. Blum, G. von Degenfeld, M.J. Merchant, H.M. Blau, and M. Bogyo Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes Nat Chem Biol 3 2007 668 677 (Pubitemid 47417706)
119. H. Kobayashi, M. Ogawa, R. Alford, P.L. Choyke, and Y. Urano New strategies for fluorescent probe design in medical diagnostic imaging Chem Rev 110 2010 2620 2640
120. F.A. Jaffer, P. Libby, and R. Weissleder Molecular imaging of cardiovascular disease Circulation 116 2007 1052 1061 (Pubitemid 47329570)
121. E. Malle, G. Waeg, R. Schreiber, E.F. Grone, W. Sattler, and H.J. Grone Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins Eur J Biochem 267 2000 4495 4503 (Pubitemid 30461082)
122. S. Baldus, C. Heeschen, T. Meinertz, A.M. Zeiher, J.P. Eiserich, and T. Munzel Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 2003 1440 1445 (Pubitemid 37176448)
123. M.L. Brennan, M.S. Penn, F. Van Lente, V. Nambi, M.H. Shishehbor, and R.J. Aviles Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 2003 1595 1604 (Pubitemid 37288567)
124. M. Exner, E. Minar, W. Mlekusch, S. Sabeti, J. Amighi, and W. Lalouschek Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol J Am Coll Cardiol 47 2006 2212 2218 (Pubitemid 43795075)
125. A. Rosell, A. Ortega-Aznar, J. Alvarez-Sabin, I. Fernandez-Cadenas, M. Ribo, and C.A. Molina Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke Stroke 37 2006 1399 1406 (Pubitemid 44305716)
126. J. Montaner, C.A. Molina, J. Monasterio, S. Abilleira, J.F. Arenillas, and M. Ribo Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke Circulation 107 2003 598 603 (Pubitemid 36176811)
127. A. Rosell, J. Alvarez-Sabin, J.F. Arenillas, A. Rovira, P. Delgado, and I. Fernandez-Cadenas A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke Stroke 36 2005 1415 1420 (Pubitemid 40967504)
128. J. Montaner, A. Rovira, C.A. Molina, J.F. Arenillas, M. Ribo, and P. Chacon Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke J Cereb Blood Flow Metab 23 2003 1403 1407 (Pubitemid 38018258)
129. J. Shepherd, S.A. Hilderbrand, P. Waterman, J.W. Heinecke, R. Weissleder, and P. Libby A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages Chem Biol 14 2007 1221 1231 (Pubitemid 350102238)
130. D.E. Sosnovik, M. Nahrendorf, N. Deliolanis, M. Novikov, E. Aikawa, and L. Josephson Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo Circulation 115 2007 1384 1391 (Pubitemid 46661480)
131. M. Nahrendorf, H. Zhang, S. Hembrador, P. Panizzi, D.E. Sosnovik, and E. Aikawa Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis Circulation 117 2008 379 387
132. K.M. Kozloff, L. Quinti, S. Patntirapong, P.V. Hauschka, C.H. Tung, and R. Weissleder Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo Bone 44 2009 190 198